# Blue Owl: portfolio, investments and team

> Blue Owl is an asset manager based in United States. 59 investments on record, 26 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/blue-owl (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Blue Owl

Last cheque observed Oct 2026; 59 cheques on record.

Email

Deploying now New fund $30M, Oct 2026 Asset manager Website unconfirmed

Growth Credit Real Assets Private Equity

Follow Blue Owl and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fblue-owl)

Deploying now

**79%** of best year **26** **cheques in 12 months**, 59 on record

Since the last cheque **23** days **00** hrs **00** min **00** sec

Median round **$189M** Rounds led **2 of 59** Sole investor **4 rounds** Mostly in **United States, 82%**

Pitch Blue Owl

## Blue Owl highlights

- 01 26 cheques in the last 12 months
- 02 Mostly Debt and Series B: 54% of its rounds
- 03 Sole investor in 4 rounds, median $675M

## What they do

- **Type:** Asset manager
- **Cheque size:** Not stated
- **Stages:** Growth
- **Sectors:** Credit Real Assets Private Equity
- **Based in:** CHICAGO, United States
- **Cold pitches:** Not accepted

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=blue-owl).

## The record

Every round we can evidence, newest first **59 appearances**

- **2026** 20 rounds
- **Oct** **[Waymo](https://millionrounds.com/company/waymo)** Debt · US · Firms' own news pages **$5.0B** With 12 others
- **Sept** **[Pyxis Oncology](https://millionrounds.com/company/pyxis-oncology)** US **$110M** With 4 others
- **Aug** **[MapLight Therapeutics](https://millionrounds.com/company/maplight-therapeutics)** US **$150M** With 2 others
- **Jul** **[BridgeBio](https://millionrounds.com/company/bridgebio)** US · Firms' own news pages **$1.0B** With 4 others
- **Jun** **[Celcuity](https://millionrounds.com/company/celcuity)** Debt · US **$500M** With 3 others
- **Jun** **[Neuron23](https://millionrounds.com/company/neuron23)** Grant · US **$2.5M** With 3 others
- **May** **[Windward Bio](https://millionrounds.com/company/windward-bio)** Series B · CH **$165M** With 4 others
- **May** **[Allica Bank](https://millionrounds.com/company/allica-bank)** Debt · GB **$20M** With 2 others
- **Apr** **[ImageneBio](https://millionrounds.com/company/imagenebio)** US **$30M** With 4 others
- **Mar** **[Nscale](https://millionrounds.com/company/nscale)** Series C · GB · 8090 Industries **$2.0B** With 14 others
- **Mar** **[Ayar Labs](https://millionrounds.com/company/ayar-labs)** Series E · US · TechStartups **$500M** *Led*
- **Mar** **[Vestwell](https://millionrounds.com/company/vestwell)** Series E · US · Crunchbase News **$385M** With 7 others
- **Mar** **[Korro Bio](https://millionrounds.com/company/korro-bio)** US **$85M** With 2 others
- **Mar** **[Scholar Rock](https://millionrounds.com/company/scholar-rock)** Debt · US **$100M** With 3 others
- **Mar** **[Ambrosia Biosciences](https://millionrounds.com/company/ambrosia-biosciences)** Series B · US **$100M** With 3 others
- **Feb** **[Allica](https://millionrounds.com/company/allica)** Series D · GB · Cogito Capital Partners **$155M** With 6 others
- **Feb** **[Deep Fission](https://millionrounds.com/company/deep-fission)** US · Ventureburn **$80M** With 3 others
- **Feb** **[Databricks](https://millionrounds.com/company/databricks)** Debt · US **$2.0B** With 4 others
- **Feb** **[Palvella Therapeutics](https://millionrounds.com/company/palvella-therapeutics)** US **$200M** With 2 others
- **Jan** **[Mirador Therapeutics](https://millionrounds.com/company/mirador-therapeutics)** Series B · US **$250M** With 6 others
- **2025** 22 rounds
- **Dec** **[Coremont](https://millionrounds.com/company/coremont)** Growth · GB · Ventureburn **$40M** *Led*
- **Dec** **[Finance of America Companies](https://millionrounds.com/company/finance-of-america-companies)** US **$50M** Sole investor
- **Dec** **[Databricks](https://millionrounds.com/company/databricks)** Growth · US · Crunchbase News **$5.0B** With 25 others
- **Nov** **[Point](https://millionrounds.com/company/point)** Debt · US **$390M** With 4 others
- **Nov** **[Clio](https://millionrounds.com/company/clio)** Growth · CA · TechStartups **$500M** With 6 others
- **Nov** **[Capital on Tap](https://millionrounds.com/company/capital-on-tap)** Debt · GB **$654M** With 5 others
- **Oct** **[Crusoe](https://millionrounds.com/company/crusoe)** Growth · US · TechStartups **$1.4B** With 8 others
- **Oct** **[TORL BioTherapeutics](https://millionrounds.com/company/torl-biotherapeutics)** Series C · US **$96M** With 4 others
- **Oct** **[Electra Therapeutics](https://millionrounds.com/company/electra-therapeutics)** Series C · US **$183M** With 4 others
- **Sept** **[Groq](https://millionrounds.com/company/groq)** Growth · US · TDK Ventures **$750M** With 11 others
- **Sept** **[Wrench Group](https://millionrounds.com/company/wrench-group)** Debt · US **$1.3B** Sole investor
- **Sept** **[Star Therapeutics](https://millionrounds.com/company/star-therapeutics)** Series D · US **$125M** With 5 others
- **Sept** **[Celcuity](https://millionrounds.com/company/celcuity)** Debt · US **$500M** With 3 others
- **Sept** **[Juniper Square](https://millionrounds.com/company/juniper-square)** Venture · US **Undisclosed** With 5 others
- **Aug** **[Klaviyo](https://millionrounds.com/company/klaviyo)** Secondary · US **$195M** With 2 others
- **Jul** **[Madrigal Pharmaceuticals](https://millionrounds.com/company/madrigal-pharmaceuticals)** Debt · US **$350M** With 1 other
- **Jul** **[MapLight Therapeutics](https://millionrounds.com/company/maplight-therapeutics)** Series D · US · Avego Management **$373M** With 8 others
- **May** **[Crusoe AI Data Center](https://millionrounds.com/company/crusoe-ai-data-center)** Venture **$12B** Sole investor
- **Mar** **[Latigo Biotherapeutics](https://millionrounds.com/company/latigo-biotherapeutics)** Series B · US **$150M** With 4 others
- **Jan** **[Perk](https://millionrounds.com/company/perk)** Series E · US **$200M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **24 named**

AJ **Alan Jay Kirshenbaum** Executive Officer of the Investment Manager i Filing they signed

AK **Alan Kirshanbaum** Executive Officer i Filing they signed

AM **Alexis Maged** Executive Officer i Filing they signed

AL **Andrew Laurino** Executive Officer i Filing they signed

AM **Andrew Morris** Secretary i Filing they signed

AM **Andrew Murphy** Secretary i Filing they signed

AR **Andrew Robert Polland** Chief Operating Officer i Form ADV

AD **Ashish Dodia** Manager of the Issuer's Managing Member i Filing they signed

AT **Avelouz Tan** Manager i Filing they signed

BS **Benoit Sansoucy** Director i Filing they signed

BC **Bryan Cole** Executive Officer i Filing they signed

CJ **Cameron J. Vail** Managing Director of the General Partner, SALI Fund Partners, LLC i Filing they signed

CC **Campbell Congdon** Managing Director of Investment Manager i Filing they signed

CD **Chris D. Crampton** Executive Officer i Filing they signed

CG **Christopher Gordon** Executive Officer i Filing they signed

CT **Christopher Temple** Director i Filing they signed

CW **Craig William Packer** Executive Officer of the Investment Manager i Filing they signed

DG **David Gross** Executive Officer i Filing they signed

DI **Douglas Irving Ostrover** Executive Officer of the Investment Manager i Filing they signed

ED **Edward D'Alelio** Director i Filing they signed

ET **Edward Truitt, Jr.** Executive Officer i Filing they signed

EK **Eric Kaye** Director i Filing they signed

FC **Fred Cummings** Trustee i Filing they signed

GR **Gary Rozier** President i Filing they signed

We also hold **75** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$254B** assets it manages, 8 advisers combined Oct 2026

**5+** funds on file numbered funds in its name

**Registered** investment adviser full reporting to the SEC

- **Legal name:** BLUE OWL Digital Infrastructure Trust Advisors LLC
- **SEC number:** CRD 337770

Funds on its Form ADV

**147** private funds, **$104B** in gross assets · filed May 2024

Private equity **77** Securitised assets **38** Hedge **32**

- Blue Owl GP Stakes IV (A) L.P. *Hedge* 731 investors $10B
- Blue Owl GP Stakes IV (B) L.P. *Hedge* 731 investors $9.7B
- Blue Owl GP Stakes V (A) L.P. *Hedge* 1,419 investors $9.6B
- Blue Owl GP Stakes V (B) L.P. *Hedge* 1,419 investors $8.8B
- Blue Owl GP Stakes III (A) L.P. *Hedge* 199 investors $7.0B
- Blue Owl GP Stakes III (B) L.P. *Hedge* 199 investors $5.6B
- Blue Owl GP Stakes V (C) L.P. *Hedge* 1,419 investors $5.4B
- Owl Rock CLO II, LTD *Securitised assets* 1 investor $4.0B
- Blue Owl First LIEN Master Fund L.P. *Hedge* 50 investors $2.5B
- Blue Owl GP Stakes II (A) L.P. *Private equity* 208 investors $2.2B

And 137 more on the filing.

New fund on file

**$30M**

raised in Oct 2026

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Growth

Median round joined **$189M** the round, not its cheque Alone, median **$675M**

Led 2 of 59 rounds **3%**

- **Sole investor:** 4 rounds
- **Last cheque:** Oct 2026

Rounds by stage said on their site

- Debt *13*
- Series B *7*
- Series C *7*
- Growth said *5*
- Series D *5*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Franklin Templeton](https://millionrounds.com/fund/franklin-templeton) 8
- [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 8
- [Goldman Sachs](https://millionrounds.com/fund/goldman-sachs) 6
- [Janus Henderson Investors](https://millionrounds.com/fund/janus-henderson-investors) 6
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 6
- [RTW Investments LLC](https://millionrounds.com/fund/rtw-investments-lp) 6

**Pitching Blue Owl?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Blue Owl. A count of rooms they were both in, not a relationship either has claimed.

[**Franklin Templeton** Private equity **8** rounds together](https://millionrounds.com/fund/franklin-templeton)[**RA Capital Management** Private equity **8** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Goldman Sachs** Private equity **6** rounds together](https://millionrounds.com/fund/goldman-sachs)[**Janus Henderson Investors** Private equity **6** rounds together](https://millionrounds.com/fund/janus-henderson-investors)[**New Enterprise Associates** VC firm **6** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**RTW Investments LLC** Growth equity **6** rounds together](https://millionrounds.com/fund/rtw-investments-lp)[**Samsara BioCapital** VC firm **6** rounds together](https://millionrounds.com/fund/samsara-biocapital)[**NVIDIA** Company **5** rounds together](https://millionrounds.com/fund/nvidia)[**OrbiMed** Private equity **5** rounds together](https://millionrounds.com/fund/orbimed)[**Sanofi** Investment firm **5** rounds together](https://millionrounds.com/fund/sanofi)[**ARCH Venture Partners** VC firm **4** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Cormorant Asset Management** Private equity **4** rounds together](https://millionrounds.com/fund/cormorant-asset-management)

## Recently backed

The latest companies Blue Owl put money into.

[**Waymo** $5.0B · Oct 2026](https://millionrounds.com/company/waymo)[**Pyxis Oncology** $110M · Sept 2026](https://millionrounds.com/company/pyxis-oncology)[**MapLight Therapeutics** $150M · Aug 2026](https://millionrounds.com/company/maplight-therapeutics)[**BridgeBio** $1.0B · Jul 2026](https://millionrounds.com/company/bridgebio)[**Celcuity** $500M · Jun 2026](https://millionrounds.com/company/celcuity)[**Neuron23** $2.5M · Jun 2026](https://millionrounds.com/company/neuron23)

## On podcasts

6 episodes naming Blue Owl in the title, and 4 more that mention it.

- [Alt Goes Mainstream](https://millionrounds.com/podcasts/alt-goes-mainstream) 6 Jan 2026 · 60 min Blue Owl's Sean Connor - a growth company in a growth industry that is investing in megatrends Mentions [Blue Owl](https://millionrounds.com/fund/blue-owl)[Blue Owl Capital](https://millionrounds.com/fund/blue-owl-capital) Apple PodcastsShow page
- [TBPN](https://millionrounds.com/podcasts/tbpn) 13 Nov 2025 · 3h 8m AI Boom Stalls, Blue Owl’s Next Move, ChatGPT Growth Concerns | Jeffrey Katzenberg, The Winklevoss Twins, Hims & Hers CEO Andrew Dudum, Coatue’s Spencer Peterson, Max Hodak, Melisa Tokmak, Tomás Puig With [Andrew Dudum](https://millionrounds.com/person/andrew-dudum)[Jeffrey Katzenberg](https://millionrounds.com/person/jeffrey-katzenberg)[Spencer Peterson](https://millionrounds.com/person/spencer-peterson) Mentions [Blue Owl](https://millionrounds.com/fund/blue-owl)[Coatue](https://millionrounds.com/fund/coatue-management)[Blue Owl Capital](https://millionrounds.com/fund/blue-owl-capital) *+3* Apple PodcastsShow page
- [Alt Goes Mainstream](https://millionrounds.com/podcasts/alt-goes-mainstream) 23 Oct 2025 · 54 min Blue Owl's Matt A'Hearn - a generational opportunity in financing digital infrastructure Mentions [Blue Owl](https://millionrounds.com/fund/blue-owl) Apple PodcastsShow page
- [Alt Goes Mainstream](https://millionrounds.com/podcasts/alt-goes-mainstream) 17 Jul 2025 · 46 min Future Proof Citywide Replay: Alt Goes Mainstream Live with Blue Owl's Marc Zahr With [Marc Zahr](https://millionrounds.com/person/marc-zahr) Mentions [Blue Owl](https://millionrounds.com/fund/blue-owl) Apple PodcastsShow page
- [Alt Goes Mainstream](https://millionrounds.com/podcasts/alt-goes-mainstream) 18 Jun 2025 · 1h 10m Blue Owl Capital's Ivan Zinn - running the long race in private credit Mentions [Blue Owl](https://millionrounds.com/fund/blue-owl)[Blue Owl Capital](https://millionrounds.com/fund/blue-owl-capital)[Leonard Green](https://millionrounds.com/person/leonard-green) Apple PodcastsShow page
- [Capital Allocators](https://millionrounds.com/podcasts/capital-allocators) 15 May 2025 · 57 min James Clarke – Building Enduring Partnerships at Blue Owl (EP.445) Mentions [Blue Owl](https://millionrounds.com/fund/blue-owl) Apple PodcastsShow page

### Mentioned in

- [TBPN](https://millionrounds.com/podcasts/tbpn) 2 Sept 2026 · 2h 17m Yapping in Neuralese, GoPro v2, Jimmy Iovine in the Ultradome | Nikesh Arora & Andrei Serban, Kurt Tenenbaum, Philip Johnston Apple PodcastsShow page
- [Sourcery](https://millionrounds.com/podcasts/sourcery) 16 Jun 2026 · 38 min Inside Harvey AI: $11B, $300M ARR, 960 Employees, 12 Offices, 13 Trillion Tokens a Month Apple PodcastsShow page
- [VC10X](https://millionrounds.com/podcasts/vc10x) 12 Mar 2026 · 9 min VC10X Pulse - Why BlackRock blocked withdrawals in a $26 Bn fund and what this means for a $2 trillion market Apple PodcastsShow page
- [Capital Allocators](https://millionrounds.com/podcasts/capital-allocators) 31 Oct 2022 · 54 min Michael Rees – Inside GP Stakes at Dyal Capital (Capital Allocators, EP.278) Apple PodcastsShow page

## Quick answers about Blue Owl

### What does Blue Owl invest in?

Blue Owl invests most often at Debt and Series B (54% of the rounds on record), in sectors such as Credit, Real Assets and Private Equity.

### How active is Blue Owl?

59 investments on record, 26 of them in the last 12 months, and it led 2. The most recent was in Oct 2026.

### What has Blue Owl invested in recently?

Its most recent investments on record: Waymo (Debt, Oct 2026), Pyxis Oncology (Undisclosed round, Sept 2026) and MapLight Therapeutics (Undisclosed round, Aug 2026).

### How big are Blue Owl's cheques?

The median round it joins is $189M.

### Does Blue Owl lead rounds?

Sometimes: it led 2 of its 59 investments on record (3%).

### Where does Blue Owl invest?

Most of the companies it backs are in the United States (82%) and the United Kingdom (13%).

### Is Blue Owl investing now?

Yes: it is actively investing, with 26 investments in the last 12 months.

### Who does Blue Owl invest alongside?

Most often Franklin Templeton (8 rounds together), RA Capital Management (8 rounds together) and Goldman Sachs (6 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=blue-owl) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=blue-owl)